Vandermeulen G - Search Results

1

Bioadhesive nanoparticles of fungal chitosan for oral DNA delivery.

Plapied L, Vandermeulen G, Vroman B, Préat V, des Rieux A. Plapied L, et al. Among authors: vandermeulen g. Int J Pharm. 2010 Oct 15;398(1-2):210-8. doi: 10.1016/j.ijpharm.2010.07.041. Epub 2010 Jul 30. Int J Pharm. 2010. PMID: 20674728

2

Chitosan-based siRNA delivery systems.

Ragelle H, Vandermeulen G, Préat V. Ragelle H, et al. Among authors: vandermeulen g. J Control Release. 2013 Nov 28;172(1):207-218. doi: 10.1016/j.jconrel.2013.08.005. Epub 2013 Aug 18. J Control Release. 2013. PMID: 23965281 Review.

3

Delivery of soluble VEGF receptor 1 (sFlt1) by gene electrotransfer as a new antiangiogenic cancer therapy.

Verrax J, Defresne F, Lair F, Vandermeulen G, Rath G, Dessy C, Préat V, Feron O. Verrax J, et al. Among authors: vandermeulen g. Mol Pharm. 2011 Jun 6;8(3):701-8. doi: 10.1021/mp100268t. Epub 2011 May 13. Mol Pharm. 2011. PMID: 21548585

4

Intracellular siRNA delivery dynamics of integrin-targeted, PEGylated chitosan-poly(ethylene imine) hybrid nanoparticles: A mechanistic insight.

Ragelle H, Colombo S, Pourcelle V, Vanvarenberg K, Vandermeulen G, Bouzin C, Marchand-Brynaert J, Feron O, Foged C, Préat V. Ragelle H, et al. Among authors: vandermeulen g. J Control Release. 2015 Aug 10;211:1-9. doi: 10.1016/j.jconrel.2015.05.274. Epub 2015 May 16. J Control Release. 2015. PMID: 25989603

5

Chitosan Nanoparticles for SiRNA Delivery In Vitro.

Ragelle H, Vanvarenberg K, Vandermeulen G, Préat V. Ragelle H, et al. Among authors: vandermeulen g. Methods Mol Biol. 2016;1364:143-50. doi: 10.1007/978-1-4939-3112-5_12. Methods Mol Biol. 2016. PMID: 26472448

6

Clinical potential of electroporation for gene therapy and DNA vaccine delivery.

Lambricht L, Lopes A, Kos S, Sersa G, Préat V, Vandermeulen G. Lambricht L, et al. Among authors: vandermeulen g. Expert Opin Drug Deliv. 2016;13(2):295-310. doi: 10.1517/17425247.2016.1121990. Epub 2015 Dec 19. Expert Opin Drug Deliv. 2016. PMID: 26578324 Review.

7

Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model.

Bausart M, Vanvarenberg K, Ucakar B, Lopes A, Vandermeulen G, Malfanti A, Préat V. Bausart M, et al. Among authors: vandermeulen g. Pharmaceutics. 2022 May 10;14(5):1025. doi: 10.3390/pharmaceutics14051025. Pharmaceutics. 2022. PMID: 35631612 Free PMC article.

8

Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(epsilon-caprolactone-co-trimethylenecarbonate) polymeric micelles.

Vandermeulen G, Rouxhet L, Arien A, Brewster ME, Préat V. Vandermeulen G, et al. Int J Pharm. 2006 Feb 17;309(1-2):234-40. doi: 10.1016/j.ijpharm.2005.11.031. Epub 2006 Jan 6. Int J Pharm. 2006. PMID: 16406402

9

Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency.

Ragelle H, Riva R, Vandermeulen G, Naeye B, Pourcelle V, Le Duff CS, D'Haese C, Nysten B, Braeckmans K, De Smedt SC, Jérôme C, Préat V. Ragelle H, et al. Among authors: vandermeulen g. J Control Release. 2014 Feb 28;176:54-63. doi: 10.1016/j.jconrel.2013.12.026. Epub 2013 Dec 31. J Control Release. 2014. PMID: 24389132

10

Optimisation of intradermal DNA electrotransfer for immunisation.

Vandermeulen G, Staes E, Vanderhaeghen ML, Bureau MF, Scherman D, Préat V. Vandermeulen G, et al. J Control Release. 2007 Dec 4;124(1-2):81-7. doi: 10.1016/j.jconrel.2007.08.010. Epub 2007 Aug 19. J Control Release. 2007. PMID: 17854939

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters